YDS Pharmatech, Inc.
October 17, 2023
Franciscan C
Oncology
Company Description: YDS Pharmatech, Inc. is heading for next-generation induced-proximity drug discovery. Using our AI+biophysics simulation combined with proteomics technologies to advance the discovery of new E3 ligase and neosubstrates.
Speakers
Country
United States
Website
http://www.yds-pharmatech.com
CEO/Top Company Official
Xing Che
Lead Product in Development
GSPT1 degrader
Development Phase of Primary Product
Pre-Clinical